| MDD (n=39) | MCI/AD (n=15) | P value |
---|---|---|---|
Age, years (SD) | 68.72 (6.04) | 81.53 (5.71) | <0.001*** |
Gender Male, n (%) | 8 (20.51) | 3 (20.0) | 0.966 |
Marriage: married or lived together, n (%) | 27 (69.23) | 7 (46.7) | 0.124 |
With family psychiatry history, n (%) | 16 (41.03) | 0 (0.0) | 0.003** |
Current smoking, n (%) | 4 (10.26) | 0 (0.0) | 0.273 |
Current alcohol use habit, n (%) | 13 (33.0) | 0 | 0.010* |
With baseline physical comorbidity, n (%) | 36 (92.3) | 12 (80.0) | 0.168 |
Onset of age, years (SD) | 51.36 (14.00) | 77.27 (4.85) | <0.001*** |
Education years, (SD) | 10.64 (3.88) | 10.53 (5.51) | 0.936 |
DDD for psychoactive medications, (SD) | Â | Â | Â |
 First-generation antipsychotics | 0.01 (0.03) | 0 | 0.435 |
 Second-generation antipsychotics | 0.13 (0.425) | 0.21 (0.389) | 0.518 |
 Mood stabilizers | 0.04 (0.02) | 0.02 (0.086) | 0.247 |
 Antidepressants | 1.08 (0.83) | 0.53 (0.550) | 0.022* |
 Benzodiazepines | 0.96 (0.806) | 0.07 (0.179) | <0.001*** |
 Cognitive enhancements | 0 | 0.71 (0.641) | <0.001*** |